Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/1999
11/17/1999CN1235547A Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators
11/17/1999CN1235540A Use of adamantane amines or structurally similar compounds for combating borna disease virus and for prevention and treatment of affective diseases and other disorders associated with BDV infections i
11/17/1999CN1235518A Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical use
11/17/1999CN1235513A Nucleic acid and amino acid sequences ralating to helicobacter pylori and vaccine compositions thereof
11/17/1999CN1235024A Composition for preventing and treating bacterial diseases of young chicken
11/17/1999CN1235023A Mixed povidone iodine disinfectant and preparing method thereof
11/17/1999CN1235014A Use of 1,2-pentanediol in cosmetic or dermatological composition containing aqueous dispersion of film-forming polymer particles, and cosmetic or dermatological composition comprising these constituen
11/17/1999CN1234976A Method for extracting sulphur containing part from garlic and preparation of oil containing sulphur part
11/17/1999CN1046535C Erythromycin A 9-0-oxime derivatives endowed with antibiotic activity and their medicinal compositions
11/17/1999CN1046524C Cephalosporin derivatives
11/17/1999CN1046523C Preparation of antimicrobial quinolonyl lactams
11/17/1999CN1046520C Bicyclic oxazine and thiazine oxazolidinone
11/17/1999CN1046510C Preparation of N-tert-butylamides
11/16/1999US5986105 Quinolone- and naphthyridonecarboxylic acid derivatives
11/16/1999US5986090 Metallized porphyrins
11/16/1999US5986089 Process for the preparation of moenomycin A
11/16/1999US5986053 Peptide nucleic acids complexes of two peptide nucleic acid strands and one nucleic acid strand
11/16/1999US5986051 Genes of Helicobacter pylori necessary for the regulation and maturation of urease and their use
11/16/1999US5986044 Polyureas, polycarbonates, polyesters and polyamide copolymers
11/16/1999US5985935 Treatment and prophylaxis of diseases caused by parasites, or bacteria
11/16/1999US5985906 Use of a combination of the squalene epoxidase inhibitor terbinafine and an azole 14-alpha-methyldemethylase inhibitor (fluconazole or itraconazole) in mycotic infections caused by azole-resistant fungal strains
11/16/1999US5985905 Useful for the treatment and/or prophylaxis of diseases associated with loss of bone mass, such as osteoporosis and related osteopenic diseases, paget's disease, hyperparathyroidism and related diseases, also antitumor
11/16/1999US5985902 Substituted isoxazole for the treatment of inflammation
11/16/1999US5985893 Decreased hygroscopicity
11/16/1999US5985890 Macrolide antibiotic having antitumor and antifungal activity
11/16/1999US5985872 2-amino-benzoxazinones for the treatment of viral infections
11/16/1999US5985867 Treating hiv infection
11/16/1999US5985859 Methods of inhibiting bacterial sialidase
11/16/1999US5985845 Methods for reducing mortality rates in poultry
11/16/1999US5985838 Peptide analogs as irreversible interleukin-1β protease inhibitors
11/16/1999US5985834 Nova- and decapeptides in the preparation of a drug for the treatment of aids
11/16/1999US5985828 Screening for agonists and antagonists of the receptor ligands, for producing diagnostic or therapeutic reagents, and for producing antibodies
11/16/1999US5985823 Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
11/16/1999US5985662 By incubating hepatitis b virus or incubating cells, tissues, or a bodily fluid which contains hepatitis b virus with an antisense oligonucleotide of given nucleotide sequences under conditions where viral replication is inhibited
11/16/1999US5985641 Non-infectious, replication-impaired, immunogenic human immunodeficiency virus type 1 retrovirus-like particles with multiple genetic deficiencies
11/16/1999US5985631 Method for preventing the activation of inactive, recombinant Helicobacter pylori apourease
11/16/1999US5985620 Polynucleotide
11/16/1999US5985613 Use of an "immunodeficiency-virus suppressing lymphokine (ISL) "to inhibit the replication of viruses, in particular of retroviruses
11/16/1999US5985610 Gene expression in host cell of conformational epitopes
11/16/1999US5985321 Soft gelatin capsule manufacture
11/16/1999US5985289 Haemophilus somnus outer membrane protein extract enriched with iron-regulated proteins
11/16/1999US5985288 Outer membrane protein P1 and peptides of Haemophilus influenzae type B
11/16/1999US5985287 Compounds and methods for treatment and diagnosis of mycobacterial infections
11/16/1999US5985286 Adenyl cyclase-hemolysin (ac-hly) protein,
11/16/1999US5985285 Vaccines for plague
11/16/1999US5985284 To protect against mucosal infection with shigella.
11/16/1999US5985283 Adenovirus E1A-Associated protein BS69, inhibitor of E1A-transactivation
11/16/1999US5985279 Humanized antibody against CD18
11/16/1999US5985277 Useful for diagnosis and treatement of corynebacterium infections and diseases.
11/16/1999US5985271 Prophylactic and theraputic treatment of group A streptococcal infection
11/16/1999US5985270 Antitumor
11/16/1999US5985265 Attaching a polyethylene glycol molecule to a consensus interferon molecule via reductive alkylation.
11/16/1999US5985264 IL-12 Stimulation of Neonatal immunity
11/16/1999US5984887 Photopheresis treatment of leukocytes
11/16/1999CA2142848C Beads having a core coated with an antifungal and a polymer
11/16/1999CA2088600C Herpes simplex virus vp16 vaccines
11/16/1999CA2078118C Cc-1065 analogs
11/16/1999CA2037900C Pokeweed antiviral protein - monoclonal antibody conjugates
11/16/1999CA2031746C Formulated medicines for enhancing the efficacy of beta-lactam antibiotics in prophylaxis and treatment against infectious disease due to pathogenic bacteria
11/16/1999CA2011116C Lyophilized bmy-28142 dihydrochloride for parenteral use
11/16/1999CA1340824C Neurokinin a antagonists
11/11/1999WO1999057304A1 Bacteriophage assay
11/11/1999WO1999057295A1 Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof
11/11/1999WO1999057292A1 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery
11/11/1999WO1999057290A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/11/1999WO1999057284A2 Attenuated influenza viruses
11/11/1999WO1999057283A1 Preparation of human papillomavirus e1 having helicase activity and method therefor
11/11/1999WO1999057280A2 Neisseria meningitidis antigens and compositions
11/11/1999WO1999057278A2 IMMUNIZATION AGAINST AND TREATMENT FOR INFECTION BY $i(H.PYLORI)
11/11/1999WO1999057271A2 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
11/11/1999WO1999057142A2 Vaccine for $i(pseudomonas aeruginosa)
11/11/1999WO1999057138A1 Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppresssant and methods of use thereof
11/11/1999WO1999057135A1 Antipicornaviral compounds, their preparation and use
11/11/1999WO1999057127A1 2'-deoxy hygromycin derivatives
11/11/1999WO1999057125A2 Hygromycin a derivatives
11/11/1999WO1999057121A1 Carbapenem derivatives, utilization thereof and intermediate compounds of the same
11/11/1999WO1999057101A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999WO1999056774A1 Viral chimeras comprised of caev and hiv-1 genetic elements
11/11/1999WO1999056772A2 Hepatitis vaccine
11/11/1999WO1999056769A2 Inhibition of helicobacter pylori proliferation
11/11/1999WO1999056765A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
11/11/1999WO1999056764A1 Method for preventing or treating a human immunodeficiency virus infection
11/11/1999WO1999056760A1 N1-modified glycopeptides
11/11/1999WO1999056755A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides
11/11/1999WO1999056737A1 Arylhydrocarbon receptor ligand antagonists
11/11/1999WO1999056726A1 Use of pharmaceutical compositions capable of being gelled in periodontology
11/11/1999WO1999056725A1 Pharmaceutical compositions capable of being gelled
11/11/1999WO1999048525A8 Hib/dtpa vaccine composition and methods of preparation
11/11/1999WO1999045016A9 Novel prodrugs for phosphorus-containing compounds
11/11/1999WO1999041402A3 Targeting of genetic vaccine vectors
11/11/1999WO1999029863A9 Human interferon-epsilon: a type i interferon
11/11/1999CA2650642A1 Neisseria meningitidis antigens and compositions
11/11/1999CA2331364A1 Arylhydrocarbon receptor ligand antagonists
11/11/1999CA2330838A1 Neisseria meningitidis antigens and compositions
11/11/1999CA2330814A1 Bacteriophage assay
11/11/1999CA2330641A1 Carbapenem derivatives, utilization thereof and intermediate compounds of the same
11/11/1999CA2330619A1 N1-modified glycopeptides
11/11/1999CA2329065A1 Pyrazole derivatives as p-38 map kinase inhibitors
11/11/1999CA2328602A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides
11/11/1999CA2328495A1 Vaccine for pseudomonas aeruginosa
1 ... 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 ... 1798